PRLD EPS Estimates
Prelude Therapeutics Incorporated
$3.23
$0.00(0.00%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$257.77M
Volume
3.25K
52W Range
$1.16 - $6.83
Target Price
$9.00
PRLD EPS estimates: the consensus estimate for Prelude Therapeutics Incorporated's current fiscal year is -$0.61 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PRLD EPS Estimates
- EPS estimate, current quarter
- $-0.16
- EPS estimate, next quarter
- $-0.17
- EPS estimate, current year
- $-0.61
- EPS estimate, next year
- $-0.79
- EPS growth, 3-year
- +19.14%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.29 |
| 2024 | $-1.68 |
| 2023 | $-2.02 |
| 2022 | $-2.44 |
| 2021 | $-2.43 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $3.23 | 0% | 3.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW